Table of Contents Author Guidelines Submit a Manuscript
Enzyme Research
Volume 2011, Article ID 128676, 8 pages
http://dx.doi.org/10.4061/2011/128676
Research Article

Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A

1Departament de Bioquímica i Biologia Molecular, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
2Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain

Received 5 April 2011; Accepted 30 May 2011

Academic Editor: John J. Tanner

Copyright © 2011 Daniel Fernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Vendrell, F. X. Aviles, and L. D. Fricker, “Metallocarboxypeptidases,” in Handbook of Metalloproteins, A. Messerschmidt, W. Bode, and M. Cygler, Eds., pp. 176–189, John Wiley & Sons, Chichester, UK, 2004. View at Google Scholar
  2. R. H. Erickson and Y. S. Kim, “Digestion and absorption of dietary protein,” Annual Review of Medicine, vol. 41, pp. 133–139, 1990. View at Google Scholar · View at Scopus
  3. J. Berger and B. Olds Schneeman, “Stimulation of bile-pancreatic zinc, protein and carboxypeptidase secretion in response to various proteins in the rat,” Journal of Nutrition, vol. 116, no. 2, pp. 265–272, 1986. View at Google Scholar · View at Scopus
  4. J. Berger and B. O. Schneeman, “Intestinal zinc and carboxypeptidase A and B activity in response to consumption of test meals containing various proteins by rats,” Journal of Nutrition, vol. 118, no. 6, pp. 723–728, 1988. View at Google Scholar · View at Scopus
  5. A. Ibarz, A. Garvín, S. Garza, and J. Pagán, “Toxic effect of melanoidins from glucose-asparagine on trypsin activity,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 2071–2075, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. J. Martin and W. J. Evans, “Phytic acid-enhanced metal ion exchange reactions: the effect on carboxypeptidase A1,” Journal of Inorganic Biochemistry, vol. 35, no. 4, pp. 267–288, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Parellada, G. Suárez, and M. Guinea, “Inhibition of zinc metallopeptidases by flavonoids and related phenolic compounds: structure-activity relationships,” Journal of Enzyme Inhibition, vol. 13, no. 5, pp. 347–359, 1998. View at Google Scholar · View at Scopus
  8. M. M. Martínez-Montemayor, G. M. Hill, N. E. Raney et al., “Gene expression profiling in hepatic tissue of newly weaned pigs fed pharmacological zinc and phytase supplemented diets,” BMC Genomics, vol. 9, article 421, 2008. View at Publisher · View at Google Scholar · View at PubMed
  9. M. A. Hilal, C. T. Ung, S. Westlake, and C. D. Johnson, “Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis,” Journal of Gastroenterology and Hepatology, vol. 22, no. 3, pp. 349–354, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Regnér, S. Appelros, C. Hjalmarsson, J. Manjer, J. Sadic, and A. Borgström, “Monocyte chemoattractant protein 1, active carboxypeptidase B and CAPAP at hospital admission are predictive markers for severe acute pancreatitis,” Pancreatology, vol. 8, no. 1, pp. 42–49, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Sáez, J. Martínez, C. Trigo et al., “Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis,” World Journal of Gastroenterology, vol. 11, no. 46, pp. 7261–7265, 2005. View at Google Scholar · View at Scopus
  12. S. Matsugi, T. Hamada, N. Shioi, T. Tanaka, T. Kumada, and S. Satomura, “Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma,” Clinica Chimica Acta, vol. 378, no. 1-2, pp. 147–153, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. F. Fialka, R. M. Gruber, R. Hitt et al., “CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma—a pilot study,” Oral Oncology, vol. 44, no. 10, pp. 941–948, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. L. Ross, I. Cheng, X. Liu et al., “Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer,” BMC Cancer, vol. 9, article 69, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. K. D. Jeffrey, E. U. Alejandro, D. S. Luciani et al., “Carboxypeptidase E mediates palmitate-induced β-cell ER stress and apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 24, pp. 8452–8457, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. J. D. Johnson, “Proteomic identification of carboxypeptidase E connects lipid-induced β-cell apoptosis and dysfunction in type 2 diabetes,” Cell Cycle, vol. 8, no. 1, pp. 38–42, 2009. View at Google Scholar · View at Scopus
  17. D. A. Tregouet, R. Schnabel, M. C. Alessi et al., “Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the Athero Gene study,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 49–57, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. L. Leung, T. Myles, T. Nishimura, J. J. Song, and W. H. Robinson, “Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI),” Molecular Immunology, vol. 45, no. 16, pp. 4080–4083, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. C. Schmuck, “How to improve guanidinium cations for oxoanion binding in aqueous solution?. The design of artificial peptide receptors,” Coordination Chemistry Reviews, vol. 250, no. 23-24, pp. 3053–3067, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Hayes and P. A. Kollman, “Electrostatic potentials of proteins. 1. Carboxypeptidase A,” Journal of the American Chemical Society, vol. 98, no. 11, pp. 3335–3345, 1976. View at Google Scholar · View at Scopus
  21. L. Banci, I. Bertini, and G. La Penna, “The enzymatic mechanism of carboxypeptidase: a molecular dynamics study,” Proteins: Structure, Function and Genetics, vol. 18, no. 2, pp. 186–197, 1994. View at Google Scholar · View at Scopus
  22. K. Zhang, J. Dong, and D. S. Auld, “A time-resolved X-Ray absorption fine structure study of substrate hydrolysis by carboxypeptidase A,” Physica B (Amsterdam), vol. 208 & 209, no. 1–4, pp. 719–721, 1995. View at Google Scholar
  23. S. Álvarez-Santos, À. González-Lafont, J. M. Lluch, B. Oliva, and F. X. Avilés, “Theoretical study of the role of arginine 127 in the water-promoted mechanism of peptide cleavage by carboxypeptidase A,” New Journal of Chemistry, vol. 22, no. 4, pp. 319–325, 1998. View at Google Scholar
  24. J. H. Cho, D. H. Kim, D. H. Kim, K. J. Lee, and K. Y. Choi, “The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A,” Biochemistry, vol. 40, no. 34, pp. 10197–10203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Xu and H. Guo, “Quantum mechanical/molecular mechanical and density functional theory studies of a prototypical zinc peptidase (carboxypeptidase A) suggest a general acid-general base mechanism,” Journal of the American Chemical Society, vol. 131, no. 28, pp. 9780–9788, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. D. H. Kim, “Chemistry-based design of inhibitors for carboxypeptidase A,” Current Topics in Medicinal Chemistry, vol. 4, no. 12, pp. 1217–1226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Adler, B. Buckman, J. Bryant et al., “Structures of potent selective peptide mimetics bound to carboxypeptidase B,” Acta Crystallographica. Section D: Biological Crystallography, vol. 64, no. 2, pp. 149–157, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. E. Bunnage and D. R. Owen, “TAFIa inhibitors in the treatment of thrombosis,” Current Opinion in Drug Discovery and Development, vol. 11, no. 4, pp. 480–486, 2008. View at Google Scholar · View at Scopus
  29. I. Bravo-Osuna, C. Vauthier, A. Farabollini, G. Millotti, and G. Ponchel, “Effect of chitosan and thiolated chitosan coating on the inhibition behaviour of PIBCA nanoparticles against intestinal metallopeptidases,” Journal of Nanoparticle Research, vol. 10, no. 8, pp. 1293–1301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Rink, A. Arkema-Meter, I. Baudoin et al., “To protect peptide pharmaceuticals against peptidases,” Journal of Pharmacological and Toxicological Methods, vol. 61, no. 2, pp. 210–218, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. D. Fernández, S. Testero, J. Vendrell, F. X. Avilés, and S. Mobashery, “The X-ray structure of carboxypeptidase a inhibited by a thiirane mechanism-based ihibitor,” Chemical Biology and Drug Design, vol. 75, no. 1, pp. 29–34, 2010. View at Publisher · View at Google Scholar · View at PubMed
  32. G. V. Odell, P. C. Ferry, L. M. Vick et al., “Citrate inhibition of snake venom proteases,” Toxicon, vol. 36, no. 12, pp. 1801–1806, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Bonferoni, G. Sandri, S. Rossi, F. Ferrari, S. Gibin, and C. Caramella, “Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties,” European Journal of Pharmaceutical Sciences, vol. 33, no. 2, pp. 166–176, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. Collaborative Computational Project number 4, “The CCP4 suite: programs for protein crystallography,” Acta Crystallographica. Section D: Biological Crystallography, vol. 50, pp. 760–776, 1994. View at Google Scholar
  35. R. J. Read, “Pushing the boundaries of molecular replacement with maximum likelihood,” Acta Crystallographica. Section D Biological Crystallography, vol. 57, no. 10, pp. 1373–1382, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. G. N. Murshudov, A. A. Vagin, and E. J. Dodson, “Refinement of macromolecular structures by the maximum-likelihood method,” Acta Crystallographica. Section D: Biological Crystallography, vol. 53, no. 3, pp. 240–255, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. I. W. Davis, L. W. Murray, J. S. Richardson, and D. C. Richardson, “MolProbity: structure validation and all-atom contact analysis for nucleic acids and their complexes,” Nucleic Acids Research, vol. 32, pp. W615–W619, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. A. Laskowski, M. W. MacArthur, E. Hutchinson, and J. M. Thornton, “PROCHECK: a program to check the stereochemical quality of protein structures,” Journal of Applied Crystallography, vol. 26, pp. 283–291, 1993. View at Google Scholar
  39. P. Emsley and K. Cowtan, “Coot: model-building tools for molecular graphics,” Acta Crystallographica. Section D: Biological Crystallography, vol. 60, no. 12, pp. 2126–2132, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. Y. Cheng and W. H. Prusoff, “Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction,” Biochemical Pharmacology, vol. 22, no. 23, pp. 3099–3108, 1973. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Fernández, E. Boix, I. Pallarès, F. X. Avilés, and J. Vendrell, “Analysis of a new crystal form of procarboxypeptidase B: further insights into the catalytic mechanism,” Biopolymers, vol. 93, no. 2, pp. 178–185, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. S. Firth-Clark, S. B. Kirton, H. M. G. Willems, and A. Williams, “De novo ligand design to partially flexible active sites: application of the ReFlex algorithm to carboxypeptidase A, acetylcholinesterase, and the estrogen receptor,” Journal of Chemical Information and Modeling, vol. 48, no. 2, pp. 296–305, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. L. D. Byers and R. Wolfenden, “A potent reversible inhibitor of carboxypeptidase A,” The Journal of Biological Chemistry, vol. 247, no. 2, pp. 606–608, 1972. View at Google Scholar · View at Scopus
  44. R. E. Galardy and Z. P. Kortylewicz, “Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues,” Biochemistry, vol. 23, no. 9, pp. 2083–2087, 1984. View at Google Scholar
  45. M. C. Bonferoni, G. Sandri, S. Rossi, F. Ferrari, and C. Caramella, “Chitosan and its salts for mucosal and transmucosal delivery,” Expert Opinion on Drug Delivery, vol. 6, no. 9, pp. 923–939, 2009. View at Publisher · View at Google Scholar · View at PubMed
  46. T. Kean, S. Roth, and M. Thanou, “Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency,” Journal of Controlled Release, vol. 103, no. 3, pp. 643–653, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. G. Ursino, E. Poluzzi, C. Caramella, and F. De Ponti, “Excipients in medicinal products used in gastroenterology as a possible cause of side effects,” Regulatory Toxicology and Pharmacology, vol. 60, no. 1, pp. 93–105, 2011. View at Publisher · View at Google Scholar · View at PubMed
  48. M. D. Del Curto, A. Maroni, L. Palugan, L. Zema, A. Gazzaniga, and M. E. Sangalli, “Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds,” Journal of Pharmaceutical Sciences, vol. 100, no. 8, pp. 3251–3259, 2011. View at Publisher · View at Google Scholar · View at PubMed
  49. M. P. Wentland, S. Raza, and Y. Gao, “96-Well plate colorimetric assay for Ki determination of (±)-2-Benzylsuccinic acid, an inhibitor of carboxypeptidase A. A laboratory experiment in drug discovery,” Journal of Chemical Education, vol. 81, no. 3, pp. 398–400, 2004. View at Google Scholar · View at Scopus